Dietary supplements do not require premarket approval by the US Food and Drug Administration (FDA), yet they can have side effects; interact with medications, food, or other supplements; or be unsafe, so it is important for clinicians to discuss dietary supplement use with patients. This article provides an overview of dietary supplement requirements related to safety, manufacturing, labeling, advertising, and adverse event reporting; discusses tainted supplements and the FDA's and Federal Trade Commission's enforcement actions against dietary supplements; and offers recommendations to clinicians on matters of key clinical and ethical importance during clinical encounters.
CITATION STYLE
Bernstein, I. B. G., & Bolte, K. L. (2022, May 1). Is My Patient Taking an Unsafe Dietary Supplement? AMA Journal of Ethics. American Medical Association. https://doi.org/10.1001/amajethics.2022.390
Mendeley helps you to discover research relevant for your work.